Orkun Ozhelvaci
BioNTech (Germany)(DE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, SARS-CoV-2 detection and testing, Influenza Virus Research Studies, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera(2022)383 cited
- → Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes(2022)218 cited
- → Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5(2022)74 cited
- → Evaluation of convenient pretreatment protocols for RNA virus metagenomics in serum and tissue samples(2015)53 cited
- → False-Positive Results in Metagenomic Virus Discovery: A Strong Case for Follow-Up Diagnosis(2014)40 cited
- → Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice(2022)34 cited
- → Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity(2023)32 cited
- → Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human sera(2021)24 cited
- → Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial(2022)16 cited